Reducing inflammation can also reduce the risk of heart disease and lung cancer.
A drug that fights inflammation can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another, a new study finds.
Researchers outside the study say the findings represent a major milestone — proof of a biologic concept that opens the door to new ways of treating and preventing cardiovascular disease in people who are still at risk despite standard therapies.
“This is fantastic,” said Dr. David J. Maron, the director of preventive cardiology at Stanford University School of Medicine. “The green light just went on for full-fledged investigation and development of effective and cost-effective new therapies.”
|Read Full Article: Drug Aimed at Inflammation May Lower Risk of Heart Disease and Cancer – The New York Times|